Statins for inflammatory bowel disease: Can off-label drug help it?

Published:November 14, 2016DOI:
      Current medications for Inflammatory Bowel Disease (IBD) do not work for all patients and sometimes stop working after one year. Looking for new cures, clinicians believe the most promising ones are not actually a new set of drugs, but a change of strategy with existing therapies. Methotrexate, Azathioprine, Ustekinumab are some of the most common off-label drugs prescribed for.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ungaro R.
        • Chang H.L.
        • Cote-Daigneaut J.
        • Mehandru S.
        • Atreja A.
        • Colombel J.F.
        Statins associated with decreased risk of new onset inflammatory bowel disease.
        Am J Gastroenterol. 2016; 111: 1416-1423
        • Khalili H.
        Editorial: statins for inflammatory bowel disease: expanding the scope of prevention.
        Am J Gastroenterol. 2016; 111: 1424-1426
        • Gazzerro P.
        • Proto M.C.
        • Gangemi G.
        • Malfitano A.M.
        • Ciaglia E.
        • Pisanti S.
        • et al.
        Pharmacological actions of statins: a critical appraisal in the management of cancer.
        Pharmacol Rev. 2012; 64: 102-146
        • Matsuoka K.
        • Kanai T.
        The gut microbiota and inflammatory bowel disease.
        Semin Immunopathol. 2015; 37: 47-55
        • Catry E.
        • Pachikian B.D.
        • Salazar N.
        • Neyrinck A.M.
        • Cani P.D.
        • Delzenne N.M.
        Ezetimibe and simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism.
        Life Sci. 2015; 132: 77-84
        • Ananthakrishnan A.N.
        • Cagan A.
        • Cai T.
        • Gainer V.S.
        • Shaw S.Y.
        • Churchill S.
        • et al.
        Statin use is associated with reduced risk of colorectal cancer in patients with inflammatory bowel diseases.
        Clin Gastroenterol Hepatol. 2016; 14: 973-979